Our findings suggest that hyperglycemia downregulates STK35 expression in the heart, leading to suppression of angiogenic gene expression, disruption of microvascular homeostasis in the myocardium, and the subsequent left ventricle dysfunction in DCM. The gene discussed is STK35; the disease is Hyperglycemia.